ACCESS TO HEPATITIS C TREATMENTS

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Motion text

That this House expresses concern over the ongoing restrictions on access to NICE-approved hepatitis C treatments in England; notes the considerable effect this cap is having on people living with hepatitis C, who are often told they face an indefinite wait before they are able to access these treatments; expresses concern over inequalities of access to care in this disadvantaged patient group as a result of the cap; further notes that the Government has yet to publish a national strategy for tackling hepatitis C in England, despite the UK's support for the World Health Organisation's goal of eliminating hepatitis C by 2030; and therefore calls on the Department of Health to develop and implement a national strategy for eliminating hepatitis C that contains clear steps towards ending the current restrictions on access to treatment.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

EDM (Early Day Motion) 931: tabled on 08 February 2017

Motion text

Signatures (18)